ASSOCIATION OF HORMONE REPLACEMENT THERAPY IN POST MENPOSALWOMEN AND CARDIOVASCULAR DISEASE
Loading...
Date
2020-02-22
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
faculty of Basic Medical Science - Libyan International Medical University
Abstract
Hormone replacement therapy (HRT) has a profound impact on the cardiovascular system in
postmenopausal women, achieved through its effects on metabolic risk factors for coronary heart disease
(CHD) and on arterial function. Observational studies have consistently shown an association between
postmenopausal HRT use and a reduced incidence of CHD. However, the largest randomized trial initially
reported no overall benefit on CHD risk. Subsequent analyses and follow-up of the study have demonstrated
a significant benefit for CHD risk in healthy women initiating estrogen therapy soon after the onset of
menopause. This benefit of early initiation of HRT has been confirmed in more recent trials. The dose and
type of hormones at initiation of therapy appears crucial to obtaining CHD benefit.
Description
Hormone replacement therapy (HRT) has been used for more than 60 years to treat menopausal estrogen
deficiency and increase longevity in postmenopausal women. However, following the publication of the
Women’s Health Initiative (WHI) study, the effect of HRT on cardiovascular risk has been the subject of
much debate. The initial findings of this study demonstrated an increased risk of coronary heart disease
(CHD) in older women, without increasing mortality.
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwised noted, this item's license is described as Attribution 3.0 United States